Article
Gender differences in aortic valve replacement: is surgical aortic valve replacement riskier and transcatheter aortic valve replacement safer in women than in men?
Author/s | Caponcello, Maria Giulia
Martín Banderas, Lucía ![]() ![]() ![]() ![]() ![]() ![]() ![]() Ferrero Rodríguez, Carmen ![]() ![]() ![]() ![]() ![]() ![]() ![]() Bramlage, Carsten Thoenes, Martin Bramlage, Peter |
Department | Universidad de Sevilla. Departamento de Farmacia y Tecnología Farmacéutica |
Date | 2020 |
Published in |
|
Abstract | Aortic stenosis (AS) is a progressive and degenerative disease that necessitates valve replacement through either surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). Various studies ... Aortic stenosis (AS) is a progressive and degenerative disease that necessitates valve replacement through either surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR). Various studies have shown that, unlike for TAVR, SAVR is associated with an elevated risk for women as compared to men. The aim of this review is to better understand the risks and their possible causes, associated with the use of both TAVR and SAVR in female patients. Our systematic review included studies published between 2012 and 2020, identified through specific searches of PubMed. Compatibility of publications, determined by the use of pre-defined inclusion/exclusion criteria, resulted in 15 articles being used in our review. Overall, more men than women undergo SAVR, but our findings confirmed that SAVR is associated with worse outcomes in women in the short-term. Reasons for a higher 30-day mortality post-SAVR in women include an increased age, higher in-hospital mortality and, possibly baseline comorbidities and anatomical differences. There was no difference observed in 30-day mortality between men and women undergoing TAVR. Female patients appear to have a better longer-term survival post-TAVR than their male counterparts. Understanding the reasons why women have worse outcomes post-SAVR is essential for ensuring appropriate treatment selection for patients with AS, as well as for achieving the best possible long-term and safety outcomes for these patients. |
Citation | Caponcello, M.G., Martín Banderas, L., Ferrero Rodríguez, C., Bramlage, C., Thoenes, M. y Bramlage, P. (2020). Gender differences in aortic valve replacement: is surgical aortic valve replacement riskier and transcatheter aortic valve replacement safer in women than in men?. Journal of Thoracic Disease, 12 (7), 3737-3746. |
Files | Size | Format | View | Description |
---|---|---|---|---|
40896-PB3-5024-R2.pdf | 236.4Kb | ![]() | View/ | |
This item appears in the following collection(s)
Except where otherwise noted, this item's license is described as: Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Related items
Showing items related by title, author, creator and subject.
-
Article
Validation of 4D Flow based relative pressure maps in aortic flows
Nolte, David; Urbina, Jesús; Sotelo, Julio; Sok, Leo; Montalba, Cristian; Valverde Pérez, Israel; Osses, Axel; Bertoglio, Cristóbal (Elsevier Science, 2021-08-15)While the clinical gold standard for pressure difference measurements is invasive catheterization, 4D Flow MRI is a ...
-
Article
Estimating central blood pressure from aortic flow: development and assessment of algorithms
Mariscal-Harana, Jorge; Charlton, Peter H; Vennin, Samuel; Aramburu, Jorge; Florkow, Mateusz Cezary; van Engelen, Arna; Valverde, Israel; Alastruey, Jordi (American Physiological Society, 2021)Central blood pressure (cBP) is a highly prognostic cardiovascular (CV) risk factor whose accurate, invasive assessment ...
-
Article
Dietary fatty acids on aortic root calcification in mice with metabolic syndrome
Naranjo, María C.; Bermúdez Pulgarín, Beatriz; García, Indara; López Martín, Sergio; Abia González, María del Rocío; García Muriana, Francisco José; Montserrat de la Paz, Sergio (Royal Society of Chemistry, 2017)Metabolic syndrome (MetS) is associated with obesity, dyslipidemia, type 2 diabetes, and chronic low-grade inflammation. ...